Costs of osteoarthritis: estimates from a geographically defined population
- PMID: 7752127
Costs of osteoarthritis: estimates from a geographically defined population
Abstract
Using the population based data resources of the Rochester Epidemiology Project and a postal survey, we estimated all costs (direct medical, indirect medical, and nonmedical) incurred among a population based prevalence cohort of individuals with osteoarthritis (OA) and a nonarthritic comparison cohort. Cost estimates were compared between the 2 groups adjusting for age and sex differences. Our results demonstrated that people with OA incur substantial incremental medical costs, not only for arthritis care, but also for the care of neurological, gastrointestinal, cardiac, and respiratory conditions compared to nonarthritics. These data also demonstrated important and statistically significantly higher levels of work disability among people with OA compared to their age and sex adjusted peers without arthritis from the same community.
Similar articles
-
Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.J Rheumatol. 1997 Jan;24(1):43-8. J Rheumatol. 1997. PMID: 9002009
-
Direct medical costs unique to people with arthritis.J Rheumatol. 1997 Apr;24(4):719-25. J Rheumatol. 1997. PMID: 9101508
-
Modeling the lifetime costs of rheumatoid arthritis.J Rheumatol. 1999 Jun;26(6):1269-74. J Rheumatol. 1999. PMID: 10381041
-
The increasing impact of arthritis on public health.J Rheumatol Suppl. 2000 Oct;60:6-8. J Rheumatol Suppl. 2000. PMID: 11032095 Review.
-
The prevalence and burden of arthritis.Rheumatology (Oxford). 2002 Apr;41 Supp 1:3-6. Rheumatology (Oxford). 2002. PMID: 12173279 Review.
Cited by
-
Evidence-Based Decision Making 6: Administrative Databases as Secondary Data Source for Epidemiologic and Health Service Research.Methods Mol Biol. 2021;2249:483-499. doi: 10.1007/978-1-0716-1138-8_26. Methods Mol Biol. 2021. PMID: 33871860
-
Barriers to accessing the culturally sensitive healthcare that could decrease the disabling effects of arthritis in a rural Mayan community: a qualitative inquiry.Clin Rheumatol. 2016 May;35(5):1287-98. doi: 10.1007/s10067-015-3061-4. Epub 2015 Sep 3. Clin Rheumatol. 2016. PMID: 26334916
-
Chondroitin for osteoarthritis.Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD005614. doi: 10.1002/14651858.CD005614.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629804 Free PMC article. Review.
-
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412. Arthritis Care Res (Hoboken). 2015. PMID: 25048053 Free PMC article.
-
Health-Related Quality-of-Life Outcomes in Patients Treated with Push-Pull OROS Hydromorphone versus Extended-Release Oxycodone for Chronic Hip or Knee Osteoarthritis Pain: A Randomized, Open-Label, Parallel-Group, Multicenter Study.Patient. 2008 Jul 1;1(3):223-38. doi: 10.2165/1312067-200801030-00009. Patient. 2008. PMID: 22272928
MeSH terms
LinkOut - more resources
Medical